REYON Pharmaceutical Co., Ltd. (KRX:102460)

REYON Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	205,603	303,360	384,347	631,111	390,433	264,446
Market Cap Growth	-12.70%	-21.07%	-39.10%	61.64%	47.64%	15.07%
Enterprise Value	399,440	498,164	550,681	726,725	401,156	228,088
Last Close Price	11210.00	16346.02	21193.22	34562.68	21329.85	14994.41
PE Ratio	49.60	84.66	52.23	116.61	101.56	53.46
PS Ratio	1.39	2.01	2.50	4.42	3.00	2.01
PB Ratio	0.83	1.22	1.55	2.57	1.70	1.20
P/TBV Ratio	1.03	1.23	1.56	2.59	1.71	1.22
P/OCF Ratio	68.26	35.09	44.03	54.01	84.89	-
EV/Sales Ratio	2.69	3.30	3.58	5.09	3.09	1.73
EV/EBITDA Ratio	57.54	76.00	61.31	117.02	64.51	21.30
EV/EBIT Ratio	116.11	281.00	123.81	470.45	242.53	34.45
EV/FCF Ratio	-22.89	-	-	-	-	-
Debt / Equity Ratio	0.62	0.91	0.85	0.85	0.26	0.15
Debt / EBITDA Ratio	18.67	34.33	23.40	33.38	9.56	3.14
Asset Turnover	0.30	0.31	0.32	0.36	0.44	0.46
Inventory Turnover	2.23	2.25	2.60	2.35	2.22	2.59
Quick Ratio	0.34	0.51	1.63	2.91	1.83	3.21
Current Ratio	0.63	0.80	2.27	3.47	2.42	3.95
Return on Equity (ROE)	0.25%	1.44%	3.02%	2.33%	1.70%	2.21%
Return on Assets (ROA)	0.51%	0.22%	0.58%	0.24%	0.35%	1.44%
Return on Capital (ROIC)	0.58%	0.24%	0.61%	0.26%	0.38%	1.60%
Return on Capital Employed (ROCE)	1.10%	0.50%	1.00%	0.40%	0.60%	2.80%
Earnings Yield	2.02%	1.18%	1.93%	0.88%	0.98%	1.87%
FCF Yield	-8.49%	-6.67%	-14.16%	-16.68%	-12.22%	-23.87%
Dividend Yield	1.29%	0.92%	0.71%	0.72%	0.94%	2.29%
Payout Ratio	66.27%	76.41%	61.38%	62.56%	150.47%	167.08%
Buyback Yield / Dilution	1.91%	-0.46%	-3.03%	-4.05%	-1.01%	0.80%
Total Shareholder Return	3.20%	0.46%	-2.32%	-3.33%	-0.08%	3.09%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.